Sickle cell disease in the era of precision medicine: looking to the future-Reference-Cited by-同舟云学术

Sickle cell disease in the era of precision medicine: looking to the future

Published:2019-11-02 Issue:6 Volume:4 Page:357-367
ISSN:2380-8993
Container-title:Expert Review of Precision Medicine and Drug Development
language:en
Short-container-title:Expert Review of Precision Medicine and Drug Development

Author:

Steinberg Martin H¹,Kumar Sara¹,Murphy George J.¹^ORCID,Vanuytsel Kim¹

Affiliation:

1. Department of Medicine, Division of Hematology/Oncology, Center of Excellence for Sickle Cell Disease and Center for Regenerative Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23808993.2019.1688658

Reference77 articles.

1. Genetic influences on F cells and other hematologic variables: a twin heritability study

2. Individual Variation in the Production and Survival of F Cells in Sickle-Cell Disease

3. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin

4. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes

5. Intravascular hemolysis and the pathophysiology of sickle cell disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A-296G variant of THBS1 gene (rs1478605) is associated with a lower frequency of stroke in a Brazilian population with sickle cell anemia;Journal of Stroke and Cerebrovascular Diseases;2024-01

2. Precision Medicine in Brain Tumors: New Approaches;Interdisciplinary Cancer Research;2024

3. Blood rheology and vascular function in sickle cell trait and sickle cell disease: From pathophysiological mechanisms to clinical usefulness;Clinical Hemorheology and Microcirculation;2023-12-07

4. Evaluation of 2D and 3D Erythroid Differentiation Protocols Using Sickle Cell Disease and Healthy Donor Induced Pluripotent Stem Cells;Cells;2023-04-10

5. In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction;American Journal of Hematology;2023-04-03